Source: Annual Congress 2013 –Research questions on how viruses affect the respiratory system



Rating:

Share or cite this content

Citations should be made in the following way:
L. Su, R. Zhou, L. Cao, K. Xiao, B. Wen, L. Xie (Sanya, Tianjin, Beijing, Shenzhen, China). Preliminary proteomics analysis for sepsis biomarkers with iTRAQ labeling and LC-MS/MS. Eur Respir J 2013; 42: Suppl. 57, 4403

Member's Comments

No comment yet.

Related content which might interest you: Discrimination of sepsis metabolic profiles revealed by LC/MS-MS based metabonomics approach Source: Annual Congress 2013 –Infection, sepsis and outcomes in ICU Year: 2013 High-throughput analysis of induced sputum from the U-BIOPRED study using novel proteomic and data mining approaches Source: Annual Congress 2013 –Origins and diagnosis of asthma Year: 2013 Metabolomic fingerprinting in the identification of biomarkers in COPD patients Source: Annual Congress 2012 - Basic and translational studies in COPD Year: 2012 Mass spectrometry proteomic biomarkers identify acute COPD exacerbations Source: Virtual Congress 2020 – Burden and predictive factors for chronic lung diseases and comorbidity Year: 2020 Metabolomic profiling differences among asthma, COPD and healthy controls: a LC-MS-based metabolomics analysis Source: International Congress 2019 – Evaluation of basic science in airway diseases Year: 2019 Identification of serum biomarkers associated with asthma phenotypes through Combinatorial Hexapeptide Ligand Libraries (CPLLs) and iTRAQ-coupled LC-MS/MS. Source: International Congress 2019 – Modelling and monitoring of airway diseases Year: 2019 Benchtop NMR-based metabolomic analysis as a diagnostic tool for tuberculosis in clinical urine samples Source: International Congress 2019 – Tuberculosis: diagnosis Year: 2019 Quantitative intact proteomics investigations of alveolar macrophages in sarcoidosis Source: Eur Respir J 2013; 41: 1331-1339 Year: 2013 Metabolomic profiling of clinical sputum samples reveals novel biomarkers for the early identification of lung cancer patients Source: International Congress 2014 – Improving diagnosis of thoracic tumours Year: 2014 Quantitative proteomic analysis: methods and applications Source: Lung Science Conference 2004 - Application of our knowledge of the basic processes of lung inflammation in lung diseases Year: 2004 Sputum supernatant profiling reveals inflammasome-associated signatures in severe asthmatics in U-BIOPRED Source: International Congress 2015 – Advances in the future treatment of severe asthma Year: 2015 Metabolic profiling detects biomarkers of protein degradation in COPD patients Source: Eur Respir J 2012; 40: 345-355 Year: 2012 Feasibility of using multiplex technology for simultaneous quantification of inflammatory proteins in exhaled particles Source: International Congress 2016 – Phenotyping asthma Year: 2016 Plasma metabolomic signature in COPD patients: Associations to proteomic profile and clinical outcomes Source: Annual Congress 2013 –COPD mechanisms Year: 2013 A liquid chromatography MS/MS metabolomics study of COPD patients Source: International Congress 2015 – Monitoring and phenotyping COPD Year: 2015 Metabolomic fingerprinting of serum samples based on direct infusion mass spectrometry for lung cancer diagnosis Source: International Congress 2017 – Clinical research in lung cancer: new valuable results on lung cancer detection, prognostic biomarkers, and tyrosine kinase inhibitors Year: 2017 Altered serum metabolomics in COPD: analysis of the SPIROMICS cohort Source: International Congress 2018 – COPD phenotypes: a1 antitrypsin deficiency and beyond Year: 2018 New approaches to tuberculosis diagnosis through the study of metabolomic profile in urine Source: Annual Congress 2013 –Tuberculosis diagnosis Year: 2013 Large-scale quantitative proteomic analysis identifies pathways in COPD-associated lung cancer Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers Year: 2015